Rifampicin, the main treatment for TB, is losing ground against drug-resistant bacteria and dormant infections, underscoring the need for smarter combination strategies. Pairing rifampicin with the ...

WASHINGTON -- Scientists might have found a way to deal drug-resistant tuberculosis a one-two punch using two old, safe antibiotics -- and studies in ill patients could begin later this year. TB is ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short ...

Immunome said on Monday its experimental drug met the main goal in a late-stage study for patients with a rare type of tumor, sending its shares up 25% in morning trade.

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. "The booming trade in illicit GLP-1s deserves a swift ...

A graphic showing, top to bottom, how DNA aptamers target two specific markers on a leukemia stem cell’s surface, enter the cell and deliver anticancer drugs, resulting in death of the cancer cell.